RVL Pharmaceuticals’ first FDA-approved product, Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1%, is also the only FDA-approved prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes. Upneeq is available through the UP+ Program, which allows providers to dispense Upneeq directly to their appropriate adult patients.
Contact: 877.482.3788, upneeq.com
